Praveensingh Hajeri
Overview
Explore the profile of Praveensingh Hajeri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida H, Sato-Dahlman M, Hajeri P, Jacobsen K, Koodie L, Yanagiba C, et al.
Transl Oncol
. 2020 Dec;
14(2):100997.
PMID: 33338875
The PAX3-FOXO1 fusion gene functions as a transactivator and increases expression of many cancer-related genes. These lead to metastases and other unfavorable outcomes for alveolar rhabdomyosarcoma (ARMS) patients. In order...
2.
Huang W, Akcakaya P, Gangaev A, Lee L, Zeljic K, Hajeri P, et al.
Exp Cell Res
. 2018 Aug;
371(1):287-296.
PMID: 30149002
The use of imatinib mesylate has greatly improved the clinical outcome for gastrointestinal stromal tumor (GIST) patients. However, imatinib resistance is still a major clinical challenge, and the molecular mechanisms...
3.
Sato-Dahlman M, Miura Y, Huang J, Hajeri P, Jacobsen K, Davydova J, et al.
Oncotarget
. 2017 Nov;
8(44):76044-76056.
PMID: 29100290
Oncolytic Adenoviruses (OAds) are one of the most promising anti-cancer agents that can induce cancer specific cell death. Recently, we generated infectivity-selective OAd, and the resultant OAd tumor-specific binding shows...
4.
Ozata D, Li X, Lee L, Liu J, Warsito D, Hajeri P, et al.
Cell Death Dis
. 2017 May;
8(5):e2759.
PMID: 28471449
Deregulation of microRNAs (miRNAs) contributes to the development and progression of many cancer types; however, their functions in the pathogenesis of testicular germ cell tumor (TGCT) remain unclear. Here, we...